Skip to content

Complementary & Integrative Healthcare for Children With Autism: A Pilot Study

A Complementary and Integrative Healthcare (CIH) Model for Children With Autism Spectrum Disorder-Related Symptoms: A Pilot Observational Study

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07458386
Acronym
UNK
Enrollment
20
Registered
2026-03-09
Start date
2026-03-16
Completion date
2027-02-01
Last updated
2026-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Keywords

Autism Spectrum Disorder, Pediatrics, Naturopathy, Complementary Therapies, Pilot Projects

Brief summary

To investigate the feasibility of implementing an online assessment battery in tandem with normal & customary complementary & integrative healthcare (CIH) provided to children with autism. The secondary aim is to assess the potential impacts of CIH on clinical outcomes.

Detailed description

The main aim of this pilot observational study is to investigate the feasibility of implementing an online assessment battery in tandem with normal & customary, fee-for-service, remotely delivered complementary & integrative healthcare (CIH, i.e., naturopathy + functional neurological rehabilitation) provided to children with significant parent-reported autism spectrum disorder (ASD)-related symptoms. The primary outcomes are 1) eligibility, 2) compliance, 3) adherence, and 4) retention. A secondary/exploratory aim is to assess the potential clinical impacts of CIH via a validated parent-reported outcome measure (i.e., Autism Treatment & Evaluation Checklist; ATEC). Data from this study will inform the feasibility of a definitive study powered to assess the effectiveness of CIH care on clinical outcomes in a pediatric population with ASD-related symptoms.

Interventions

None listed

Sponsors

Life University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* 3-12 years of age * Baseline ATEC score \>71

Exclusion criteria

\- History of epilepsy

Design outcomes

Primary

MeasureTime frameDescription
Proportion of enrollees who are eligible to participateFrom enrollment to baseline ATEC submission (up to 48-hours).The number of enrollees (i.e., participants who consent) who score \>71 on the baseline Autism Treatment \& Evaluation Checklist (ATEC), divided by the total number of enrollees. This assesses 'Eligibility'.
Proportion of participants complying with instructionsFrom enrollment to the end of participation (up to 6-months)The number of participants submitting all online ATECs within the 48-hour submission window, divided by the total number of participants. This assesses 'Compliance'.
Proportion of participants adhering to recommendationsFrom enrollment to the end of participation (up to 6-months)The number of participants attending ≥90% of scheduled online check-ins with the CIH practitioners, divided by the total number of participants. This assesses 'Adherence'.
Proportion of participants retained in the studyFrom enrollment to the end of the 6-month study periodThe number of participants submitting the 5th and final ATEC, divided by the total number of participants. This assesses 'Retention'.

Secondary

MeasureTime frameDescription
Change in ATEC scoresBaseline; ~1 month; ~3 months; ~4 months; ~6 monthsChange in ATEC scores from baseline. The ATEC is a 77-item parent-report questionnaire encompassing four distinct domains (i.e., speech/language, sociability, sensory/cognitive awareness, \& health/physical/behavior) designed to track the progress of individuals with ASD-related symptoms. Total scores on the ATEC range from 0 to 179 with higher scores indicating greater severity of symptoms.

Countries

United Kingdom

Contacts

PRINCIPAL_INVESTIGATORTyson Perez, DC, PhD

Life University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026